NYSE - Nasdaq Real Time Price USD

Chemed Corporation (CHE)

617.95

+1.44

(+0.23%)

At close: April 24 at 4:00 PM EDT

614.40

-3.55

(-0.57%)

After hours: April 24 at 7:57 PM EDT

Chemed (CHE) Q1 Earnings Miss Estimates

Chemed (CHE) delivered earnings and revenue surprises of -4.94% and 0.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 9 hours ago

CHE
+0.23%
Chemed Corp (CHE) Q1 2024 Earnings: Mixed Results Amidst Segment Variances

Chemed Meets Revenue Projections But Sees Divergent Segment Performances

GuruFocus.com 10 hours ago

CHE
+0.23%
Chemed Reports First-Quarter 2024 Results

CINCINNATI, April 24, 2024--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2024, versus the comparable prior-year period.

Business Wire 11 hours ago

CHE
+0.23%
Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Simply Wall St. 3 days ago

CHE
+0.23%
Here's Why You Should Retain Chemed (CHE) Stock for Now

Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.

Zacks 7 days ago

CHE
+0.23%
SYK

DVA
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama

CINCINNATI, April 17, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase.

Business Wire 7 days ago

CHE
+0.23%
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 15 days ago

CHE
+0.23%
Chemed Corporation (CHE) Rose 13% in Q4

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. Global equity markets closed out 2023 with their highest quarterly returns this year, following a period of weakness. In the fourth quarter, the strategy returned 14.87% (gross) and 14.59% (net) […]

Insider Monkey 21 days ago

CHE
+0.23%
Chemed Corp Executive Vice President Spencer Lee Sells Company Shares

Chemed Corp (NYSE:CHE), a company that operates through its two wholly-owned subsidiaries, VITAS Healthcare Corporation and Roto-Rooter, recently witnessed an insider sale.

GuruFocus.com 23 days ago

CHE
+0.23%
Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25

CINCINNATI, April 01, 2024--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, following the close of trading on the New York Stock Exchange.

Business Wire 23 days ago

CHE
+0.23%
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 27 days ago

CHE
+0.23%
DVA
Chemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 Shares

Brian Judkins, Vice President and Chief Legal Officer of Chemed Corp (NYSE:CHE), has sold 11,158 shares of the company on March 20, 2024, according to a recent SEC filing.

GuruFocus.com last month

CHE
+0.23%
Chemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?

Most readers would already be aware that Chemed's (NYSE:CHE) stock increased significantly by 10% over the past month...

Simply Wall St. last month

CHE
+0.23%
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?

Investors are optimistic about Chemed (CHE) on strong performance across the VITAS and Roto-Rooter segments.

Zacks last month

CHE
+0.23%
SYK

DVA
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care

Chemed's (CHE) VITAS segment is set to acquire the hospice assets of Covenant Care in Florida and Alabama.

Zacks last month

CHE
+0.23%
CAH

SYK
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

CINCINNATI, March 13, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant’s hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Ma

Business Wire last month

CHE
+0.23%
Here's Why You Should Add Cigna (CI) Stock to Your Portfolio

Cigna's (CI) strong Evernorth and Cigna Healthcare segments, value enhancing initiatives and a positive 2024 outlook poise it well for growth.

Zacks last month

CI

CHE
+0.23%
Teladoc Health (TDOC) Unveils Solution to Ease Weight Loss

Teladoc Health (TDOC) expands weight management capabilities by coming up with a tailored solution that aims to reduce obesity-related medical care expenses for members.

Zacks last month

TDOC

CHE
+0.23%
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference

CINCINNATI, March 08, 2024--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024, at approximately 12:00 p.m. (ET).

Business Wire last month

CHE
+0.23%
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks last month

CHE
+0.23%

Performance Overview

Return	CHE	S&P 500
YTD	+5.75%	+6.33%
1-Year	+9.35%	+22.70%
3-Year	+33.27%	+21.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Chemed Corporation (CHE)

Chemed (CHE) Q1 Earnings Miss Estimates

Chemed Corp (CHE) Q1 2024 Earnings: Mixed Results Amidst Segment Variances

Chemed Reports First-Quarter 2024 Results

Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital

Here's Why You Should Retain Chemed (CHE) Stock for Now

VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Chemed Corporation (CHE) Rose 13% in Q4

Chemed Corp Executive Vice President Spencer Lee Sells Company Shares

Chemed To Report First-Quarter 2024 Earnings April 24, Related Conference Call To Be Held On April 25

Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?

Chemed Corp VP and Chief Legal Officer Brian Judkins Sells 11,158 Shares

Chemed Corporation's (NYSE:CHE) Stock Is Going Strong: Have Financials A Role To Play?

Chemed (CHE) Reaches a New 52-Week High: What's Driving It?

Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care

VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

Here's Why You Should Add Cigna (CI) Stock to Your Portfolio

Teladoc Health (TDOC) Unveils Solution to Ease Weight Loss

Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference

Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"

Performance Overview